Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMyeloablative AgonistsTreatment OutcomeBusulfanGraft vs Host DiseaseLymphoma, Non-HodgkinRemission InductionBone Marrow TransplantationGraft SurvivalAntineoplastic Agents, AlkylatingHematopoietic Stem CellsEtoposideRecurrenceThiotepaSalvage TherapyVincristineCarmustineCytophagocytosisDisease-Free SurvivalIfosfamideAmyloidosisBoronic AcidsPyrazinesThalidomideSurvival RateRetrospective StudiesCytarabineDexamethasoneHodgkin DiseaseStem CellsHematopoiesisCord Blood Stem Cell TransplantationPrednisoneSurvival AnalysisTransplantation ChimeraDoxorubicinNeoplasmsTissue DonorsTime FactorsWhole-Body IrradiationInfectionLymphoma, T-CellAntineoplastic AgentsPOEMS SyndromePlatelet CountHistocompatibilityBone MarrowFollow-Up StudiesHistocompatibility TestingCarboplatinImmunosuppressive AgentsBone Marrow PurgingLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabinePlasma CellsBlood Cell CountRecombinant ProteinsLeukemiaLymphomaPrognosisImmunophenotypingProspective StudiesFatal OutcomeBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesMyeloma ProteinsMyelodysplastic SyndromesFlow CytometryAnemia, AplasticParaproteinemiasBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone Marrow CellsLeukocytes, MononuclearT-LymphocytesHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellMaintenance Chemotherapy